Navigation Links
Delcath to Webcast Management's Presentation at Annual Meeting of Stockholders
Date:5/21/2012

NEW YORK, May 21, 2012 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) will host a live webcast of management's presentation to shareholders at the Company's annual stockholder meeting on May 23, 2012 at 10:00 a.m ET at The Michelangelo Hotel in New York City. The presentation will commence at approximately 10:15 a.m ET.

To listen to the live webcast and view slides of the presentation during or after the event, please visit the Investor Relations section of the Company's website at www.delcath.com. A replay will be available for ninety days after the event.

About Delcath SystemsDelcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath announced that its randomized Phase III clinical trial for patients with metastatic melanoma in the liver had successfully achieved the study's primary endpoint of extended hepatic progression-free survival. The Company also completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Delcath Hepatic CHEMOSAT® delivery system in April 2011 and for the second generation hemofiltration cartridge for CHEMOSAT in April 2012. The right to affix the CE mark allows the Company to market and sell the CHEMOSAT system in Europe. The Company has not yet received FDA approval for commercial sale of its system in the United States. The Company continues with the preparation of its NDA submission and intends to seek FDA approval for
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Highlights First Quarter 2012 And Recent Accomplishments
2. Delcath Systems, Inc. Secures $20 Million Credit Facility
3. Delcath Announces Agreement With Istituto Nazionale Tumori Fondazione G. Pascale for Further Expansion of CHEMOSAT in Italy
4. Delcath Announces Agreement with Instituto Oncologico Baselga for Launch of CHEMOSAT in Spain
5. Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France
6. Delcath Announces First CHEMOSAT Procedures in Germany
7. Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System
8. Delcath CHEMOSAT Presented as Innovative Treatment for Liver Metastases by European Institute of Oncology
9. Delcath Receives Regulatory Approval to Commercialize Hepatic CHEMOSAT® Delivery System in Australia
10. Delcaths Ireland Operations Achieves ISO 13485 Certification
11. Delcath Announces Agreement With the Frankfurt University Hospital for Launch of Hepatic CHEMOSAT Delivery System in Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... FORT MYERS, Fla. , Jan. 23, 2015  Today ... approval of Novartis, Bexsero® for the prevention of ... to 25. Bexsero and Pfizer,s vaccine Trumenba®, which received ... in helping prevent this devastating disease. ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third of ... of those with private insurance, filled a prescription for an ... report in this week,s Morbidity and Mortality Weekly Report (MMWR). ... providers to treat moderate to severe pain.  They are also ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... , SHANGHAI , May 11 /PRNewswire-Asia/ -- ... Hao Zhou as Chief Financial Officer,effective immediately. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) , ... Mr. Zhou joined the company in May 2009 ...
... Dynatronics Corporation (Nasdaq: DYNT ) plans to release financial results for its ... 17, 2010 .   , , , ... conference call for investors later that day at 1:30 p.m. ET to ... use passcode: 9921511. , , , ...
Cached Medicine Technology:WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer 2WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer 3
(Date:1/22/2015)... The City of West Hollywood hosted a news ... the 42nd anniversary of the Supreme Court decision Roe v. Wade, ... years since the Roe vs. Wade decision and the fight to ... ever,” said City of West Hollywood Councilmember Abbe Land. “We need ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... January 23, 2015 Angelweddingdress is a famous ... invites its customers to follow it on Facebook, Twitter, and ... Valentine’s Day gift. Angelweddingdress draws a lottery every week. , ... to Feb. 28, 2015. Click Angelweddingdress homepage for ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
... , WEDNESDAY, Aug. 25 (HealthDay News) -- Two of ... a connection, with new research suggesting that having insulin resistance ... brain plaques associated with Alzheimer,s disease. After adjusting for ... the highest levels of fasting insulin had nearly six times ...
... has filed an Investigational New Drug (IND) application with ... begin a Phase I safety clinical trial for chronic ... This multicenter Phase I safety trial will enroll a ... patients, with an American Spinal Injury Association (ASIA) Grade ...
... WEDNESDAY, Aug. 25 (HealthDay News) -- Cholesterol-lowering statins could ... among patients who are deemed to have an "intermediate ... The finding specifically applies to those men and women ... of a protein linked to inflammation (the so-called high ...
... Mayo Clinic discovered several years ago that laboratory samples of ... help them find new treatments for this lethal disease were ... evident that the situation in their lab was common throughout ... were supposed to originate from patients with this rare thyroid ...
... immunity to mumps is high in the United ... improved to prevent future outbreaks, according to a ... in the September 1, 2010 issue of The ... found in most parts of the worldcan cause ...
... 24, 2010) What does it feel like to return ... it has been difficult during astronaut training to realistically simulate ... Dr. Steven Moore leads a research group that has ... the sensory and mobility disturbances commonly experienced by astronauts after ...
Cached Medicine News:Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 2Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 3Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 4Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 2Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 3Health News:Study Suggests Statins Could Help Some With Normal Cholesterol 2Health News:Study Suggests Statins Could Help Some With Normal Cholesterol 3Health News:Mayo researchers develop new laboratory cell lines to study treatment for ATC 2Health News:Mayo researchers develop new laboratory cell lines to study treatment for ATC 3Health News:Mumps vaccine coverage should be improved, study finds 2Health News:System uses electrical trickery on the brain to induce realistic spaceflight effects 2Health News:System uses electrical trickery on the brain to induce realistic spaceflight effects 3
The double beveled oblique blade provides a true, straight incision. Penetrating through Bowman's and Descemet's membranes without inducing corneal distortion. No need to "Dimple Down"....
... The DioLite 532 laser is indicated ... pigmented skin lesions such as telangiectasia, ... wine stains, lentigines, dermatosis papulosis nigra ... offers unsurpassed reliability, a selection of ...
... Fingertips a comprehensive pocket-sized reference ... information on the evaluation and management of ... people. Updated annually. The complete content is ... versions for Pocket PC- and Palm-based PDAs ...
... is a fully integrated custom assay service that ... upon the assay of interest, the customer simply ... and we will provide a protocol and a ... the test in the laboratory. This will help ...
Medicine Products: